logo

APAC Apheresis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Asia Pacific Apheresis Equipment Market and the market is segmented by Product, Indication (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Indications), Procedure, and Geography. The market provides the value (in USD million) for the above-mentioned segments.

Home Market Analysis Healthcare Research Medical Devices Research Treatment Equipment Research Apheresis Research Asia Pacific Apheresis Industry

Asia Pacific Apheresis Market Size

View Global Report
Asia Pacific Apheresis Market_1
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 0.74 Billion
Market Size (2029) USD 1.22 Billion
CAGR (2024 - 2029) 10.57 %

Major Players

Asia Pacific Apheresis Market

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia Pacific Apheresis Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Asia Pacific Apheresis Market Analysis

The Asia Pacific Apheresis Market size is estimated at USD 0.74 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 10.57% during the forecast period (2024-2029).

The major factors contributing to the growth of the Asia Pacific Apheresis market are increasing disease burden, the rise in demand for Blood Component Technology and associated safety, and technological advancements in the development of new apheresis techniques. However, factors such as high capital investment and costs associated with apheresis procedures are expected to restrain the market.

Apheresis Services have now become a popular mode of treatment for multiple complex immune disorders, and there has been a remarkable change in the scenario pertaining to therapeutic apheresis in Asia-Pacific. With the increasing number of diseases and accident cases, along with technological advancements in Apheresis Equipment, the market studied is expected to experience a boost during the forecast period. Additionally, the rising number of government initiatives, blood donation camps, and increasing awareness about Donor Apheresis are factors responsible for the growth of the market studied. Apheresis technology is expensive. It is also technically and medically demanding.

Asia Pacific Apheresis Market Trends

This section covers the major market trends shaping the APAC Apheresis Market according to our research experts:

Neurological Disorders is Expected to Grow with High CAGR in the Indication Segment

The pattern of neurologic diseases in Asia is largely similar to that in Western countries, with cerebrovascular diseases, headache, and epileptic seizures being the most common complaints. The high prevalence of epileptic seizures is contributing to the growth of the APAC Epilepsy Therapeutic Market in the region.

Disease features that are specific to Asia include a high proportion of strokes among the youth, mostly from premature atherosclerosis, a high prevalence of intracranial vs extracranial diseases, the relative commonality of neuromyelitis optica and the optic-spinal form of multiple sclerosis (MS), and high incidences of sex-linked dystonia and Parkinson's disease. Plasmapheresis is one of the well-established therapeutic procedures that is usually used in many neurological autoimmune disorders. It is thought that the effects of plasma exchange occur through the elimination of pathognomonic inflammatory mediators, including autoantibodies, complement components, and cytokines. Most of the neurological disease treatments benefit from therapeutic apheresis procedures such as plasmapheresis, and these effects most likely occur through the removal of harmful pathogenic autoantibodies and associated inflammatory mediators.

Asia Pacific Apheresis Market_2

Asia Pacific Apheresis Industry Overview

The Asia Pacific Apheresis market is moderately competitive and consists of several major players. In terms of market share, a few major players currently dominate the apheresis market, particularly in the area of Apheresis Devices and equipment. With the increasing prevalence of diseases in the Asia Pacific region, the usage of apheresis and the demand for Apheresis Machines is expected to rise, thereby more players are expected to enter the market. Some of the major players in the market are Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation and Terumo Corporation, who offer a wide range of Apheresis Equipment and services.

Asia Pacific Apheresis Market Leaders

  1. Asahi Kasei Corporation

  2. B. Braun Melsungen AG

  3. Cerus Corporation

  4. Kaneka Corporation

  5. Terumo Corporation

*Disclaimer: Major Players sorted in no particular order

Asia Pacific Apheresis Market_4
Need More Details on Market Players and Competitors?
Download PDF

Asia Pacific Apheresis Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Disease Burden in Asia

      2. 4.2.2 Rise in Demand for Blood Components and Associated Safety

      3. 4.2.3 Technological Advancement in the Development of New Apheresis Techniques

    3. 4.3 Market Restraints

      1. 4.3.1 High Capital Investment and Cost Associated with Apheresis Procedures

      2. 4.3.2 Risk of Blood Contamination

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Devices

      2. 5.1.2 Disposables

    2. 5.2 By Indication

      1. 5.2.1 Renal Disorders

      2. 5.2.2 Hematological Disorders

      3. 5.2.3 Neurological Disorders

      4. 5.2.4 Autoimmune Disorders

      5. 5.2.5 Other Indications

    3. 5.3 By Procedure

      1. 5.3.1 Plasmapheresis

      2. 5.3.2 Plateletpheresis

      3. 5.3.3 Erythrocytapheresis

      4. 5.3.4 Leukapheresis

      5. 5.3.5 Other Procedures

    4. 5.4 Geography

      1. 5.4.1 China

      2. 5.4.2 Japan

      3. 5.4.3 India

      4. 5.4.4 Australia

      5. 5.4.5 South Korea

      6. 5.4.6 Rest of Asia Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Asahi Kasei Corporation

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Cerus Corporation

      4. 6.1.4 Kaneka Corporation

      5. 6.1.5 Terumo Corporation

      6. 6.1.6 Fresenius SE & Co. KGaA

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia Pacific Apheresis Industry Segmentation

Apheresis is a medical technique, where the blood of an individual, either a donor or patient, is passed through an apparatus that separates a particular constituent and returns the rest of the blood to the circulatory system. This is an extracorporeal therapy.

By Product
Devices
Disposables
By Indication
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Other Indications
By Procedure
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Procedures
Geography
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Need A Different Region Or Segment?
Customize Now

Asia Pacific Apheresis Market Research FAQs

The Asia Pacific Apheresis Market size is expected to reach USD 0.74 billion in 2024 and grow at a CAGR of 10.57% to reach USD 1.22 billion by 2029.

In 2024, the Asia Pacific Apheresis Market size is expected to reach USD 0.74 billion.

Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation and Terumo Corporation are the major companies operating in the Asia Pacific Apheresis Market.

In 2023, the Asia Pacific Apheresis Market size was estimated at USD 0.67 billion. The report covers the Asia Pacific Apheresis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia Pacific Apheresis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

APAC Apheresis Industry Report

Statistics for the 2024 APAC Apheresis market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. APAC Apheresis analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

APAC Apheresis Market Report Snapshots

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

APAC Apheresis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)